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ABSTRACT 
____________________________________________________________ 
Background: The D-dimer test is commonly requested in an emergency 
department to confirm or exclude clinically suspected venous thrombosis. In 
this setting, the D-dimer is used in conjunction with the Wells clinical score 
and other investigation such as duplex doppler, V/Q scan or CT scan to make 
a definitive thrombosis diagnosis. In a typical South African private hospital 
setting, such as Flora Clinic, it has not yet been established as to how many 
of the requested D-dimers are positive, what the impact and contribution of 
this result is on patient management and outcome in an emergency 
department. In the era of diagnostic test cost cutting and evidence based 
practice, this knowledge is important in informing rational decision making by 
emergency practitioners and also as part of auditing and improving the 
implementation of diagnostic pathways. The aim of this study was to establish 
the prevalence of D-dimer positivity in an emergency department, to 
determine in how many patients venous thrombosis was part of the 
documented differential diagnosis and if patients with a positive D-dimer test 
were managed in accordance with published clinical management 
recommendations. 
Materials and methods: This study is a retrospective cross-sectional 
analysis. All D-dimer tests requested at Flora Clinic emergency department 
from 1 November 2008 to 31 May 2009 were reviewed. The percentage of 
positive results was calculated from the total D-dimer tests conducted by the 
laboratory, as requested from the emergency department during the defined 
 vi 
study period. Clinical notes and records of those patients with positive results 
were de-anonymised and de-identified, using a data capture sheet. The 
clinical notes of the patients with a positive D-dimer were reviewed to see 
what impact the D-dimer result had in the management and outcome of these 
patients in the emergency department. 
Results: There were 365 D-dimer tests conducted in the Flora Clinic 
emergency department, within the study period. Out of these 145 patients 
had a positive D-dimer test, of which 144 met further inclusion criteria. The 
study population had a mean age of 62 years with 53% men in the study 
sample. Twenty two patients‟ patient records were missing. They still formed 
part of the intent-to-treat analysis, although the data were not available 
beyond demographic data collection. The prevalence of a positive D-dimer 
test, out of all D-dimer tests conducted, between 1 November 2008 and 30 
May 2009 within the Flora Clinic emergency department was 39%. The 
diagnosis of venous thrombosis was considered in 25% of patient records. 
The higher the D-dimer level the more likely the emergency practitioner was 
to admit the patient to hospital.  No association could be found between age 
or sex and D-dimer value. No patient record had a formal pre-test probability 
evaluation recorded, although some elements of the Wells Score were 
recorded in all the clinical notes. Among the special investigations requested 
in the emergency department, 11% were in accordance with published 
treatment protocol. Out of these 3% involved chest imaging. In 10% of the 
patient records the management initiated in the emergency department was 
according to recognised treatment protocol. 
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Conclusion: The study results suggest that the assessment of pre-test 
probability is not done in a formalised manner and that positive D-dimer tests 
are either misinterpreted or that the emergency practitioners do not have 
sufficient knowledge regarding the correct management of a positive D-dimer 
test. The study identified the current trend of practice among emergency 
practitioners in the South African environment. Further studies evaluating the 
reasons for and methods to improve the under-utilisation of both clinical 
prediction rules and established treatment protocols will be useful. 
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CHAPTER 1 
1.0 INTRODUCTION 
1.1 General introduction to venous thrombosis (VT) 
 
Venous thrombosis (VT) is a spectrum of diseases including deep vein 
thrombosis (DVT) and pulmonary embolism (PE) (Hargett&Tapson, 2008). 
PE is defined as the occlusion of the pulmonary arterial bed which may 
lead to acute life-threatening, but potentially reversible right ventricular 
strain and failure (The Task Force for the Diagnosis and Management of 
Acute Pulmonary Embolism of the European Society of Cardiology, 2008) 
(ESC Task Force, 2008). DVT is a term used to describe the formation of a 
thrombus in the deep venous system. These thrombi serve as the main 
source for pulmonary emboli. PE is a diagnosis often missed in the 
emergency department (ED) because it presents with non-specific signs 
and symptoms not easily assigned to the illness (ESC Task Force).  PE 
and DVT are conditions at different ends of the same disease spectrum 
(Tapson, 2008). 
 
1.1.1 Epidemiology of VT 
 
According to United States of America (USA) statistics collected between 
1979 and 1999, PE has a prevalence of 0,4% among hospitalised patients. 
In view of its non-specific clinical presentation it is difficult to determine the 
prevalence accurately. This is supported by data from Sweden where PE 
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was considered to be the main cause of death in 13,1% of cases. The 
incidence of PE within the same period and population was only 2%. (ESC 
Task Force, 2008). 
 
PE is a complication of between 60-80% of DVTs, of which 50% will 
present asymptomatically. Despite being the 3rd most common cause of 
death in hospitalised patients, the diagnosis is still missed in up to 70% of 
cases. (Bulger,Jacobs&Patel, 2004). Among patients who develop PE 
between 7 to 11% will have a fatal event (ESC Task Force, 2008).  
 
1.1.2 Pathophysiology 
 
The main source of pulmonary emboli is thrombi from the deep venous 
system. In the 19th century Virchow identified a triad of predisposing 
factors for the formation of a venous thrombus (Ouellette, 2011). These 
include venous stasis, intimal blood vessel changes and changes to 
coagulation protein properties. Once these predisposing factors are 
present a platelet nidus forms near a valve in the lower extremities.  A 
thrombus is formed with the aggregation of more platelets, as well as fibrin 
deposits (Ouellette, 2011).   
 
When a part of this thrombus breaks off from its original location it is 
referred to as an embolus.  The embolus has the potential to travel via the 
bloodstream to remote parts of the body and occlude veins.  This process 
is referred to as embolisation. Throughout the process of thrombus 
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formation the endogenous thrombolytic system helps with partial 
dissolution of the thrombus (Ouellette, 2011).  
 
A PE mainly originates from thrombi in the deep venous system of the 
lower extremities. From there an embolus travels to the lung. Large 
thrombi will lodge at the bifurcation of the main pulmonary artery causing 
hemodynamic compromise. Smaller thrombi end their journey in the 
peripheral lung vessels causing pleuritic chest pain, among other 
symptoms. (Ouellette, 2011).  
 
Large and multiple thrombi have the potential to increase pulmonary 
vascular resistance to a level which cannot be overcome by the right 
ventricle. This can lead to sudden death. Alternatively patients can present 
with syncope or hypotension, which can progress to shock and death 
secondary to right ventricular failure. (ESC Task Force, 2008).  
 
1.1.3 Predisposing factors for development of VT 
 
PE and DVT have the same predisposing factors (ESC Task Force, 2008).  
Although VT can occur in up to 20% of patients without any identifiable risk 
factors, one or more of these are usually identified (Goldhaber,Visani&De 
Rosa, 1999). VT may be a   result of hereditary risk factors, acquired risk 
factors or an interaction between hereditary and acquired factors. Some of 
these risk factors are presented in Table 1.1. 
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The incidence of VT increases with age.  About 65% of patients diagnosed 
with PE are 60 years and older. Eight-fold higher rates are seen in patients 
over 80 years compared to those younger than 50 years. (Hansson, Welin, 
Tibblin et al., 1997). 
 
Kabrhel et al. also found an association between physical inactivity and the 
incidence of PE. In a study population of 69 950 females, they found that 
the risk of PE was more than twice in women who spent most of the day 
sitting compared to those who were more active (Kabrhel, Courtney, 
Camargo et al., 2010).  
 
The identification and estimation of the significance of predisposing factors 
may be helpful in both the assessment of clinical probability for diagnostic 
purposes, as well as for making decisions regarding primary prevention 
(ESC Task Force, 2008). VT has the potential to recur, especially in 
patients where the thrombosis was not provoked by an event like surgery, 
trauma, immobilisation, pregnancy or female hormonal intake (Eichinger, 
Heinze, Jandeck et al., 2010) . Using a scoring system, incorporating 
factors like sex, location of the initial DVT and D-dimer level, might be 
useful, in these patients, to predict further recurrences (Eichinger et al., 
2010). 
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Table 1.1 Predisposing risk factors for the development of VT 
(Modified from Tapson, 2008) 
Category  Risk factors 
Hereditary 
 
Antithrombin deficiency; Protein C deficiency 
Protein S deficiency; Factor V Leiden, Activated Protein C 
resistance (APCR); Prothrombin gene mutation; 
Dysfibrinogenemia; Plasminogen deficiency 
Acquired Reduced mobility; Advanced age; Cancer; Acute medical 
illness; Major surgery; Trauma; Spinal cord injury; Pregnancy 
and postpartum; Polycythemia vera; Antiphospholipid 
antibody syndrome; Central venous catheterisation; Limb 
Immobiliser or cast 
Probable Elevated lipoproteins; Low tissue- factor pathway inhibitor 
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1.2 Diagnosis of VT 
 
Due to the non-specific signs and symptoms with which patients with VT 
can present, patients are diagnosed through having a high index of 
suspicion and through utilisation of clinical prediction tools to determine 
which group of patients will need special investigations to either confirm or 
exclude VT. The special investigations include both laboratory testing, as 
well as imaging techniques.  
 
Through clinical evaluation of a clinical prediction tool the probability of VT 
is assessed. According to the calculated pre-test probability a certain 
pathway is followed on a diagnostic algorithm (see Figure 1.1 and 1.2 
below).  At the end of the diagnostic process the clinician will arrive at two 
possible endpoints: „confirmed VT‟ or „excluded VT‟. „Confirmed VT‟ is a 
probability of VT high enough to justify the need for further specific 
treatment. The term „excluded VT‟ is a probability of VT low enough to 
justify withholding treatment in a patient with an acceptable low risk, 
despite a clinical suspicion of PE. (ESC Task Force, 2008).  
 
To classify a diagnostic strategy for VT as safe, the overall post-test 
incidence of VT should be less than 1% with a negative predictive value of 
more than 99 to 100% during a three month follow-up period (Michiels, 
Gadisseur, van der Planken et al., 2006).  
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Figure 1.1 Diagnostic algorithm for suspected PE (Tapson, 2008) 
 
 
Figure 1.2 Diagnostic algorithm for suspected DVT (Scarvelis&Wells, 2006) 
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1.2.1 Clinical presentation 
 
Being aware of the range of symptoms and signs of VT may reduce 
diagnostic delays; therefore it is important to select an appropriate 
diagnostic strategy as well as interpretation of the diagnostic test results 
(ESC Task Force, 2008). 
Leg pain, swelling or warmth of the skin overlying a deep venous thrombus 
may serve as a clue that a patient has a DVT (Tapson, 2008). More than 
90% of patients with PE will present with dyspnoea, tachypnoea or chest 
pain. Patients rarely present with syncope, but when it occurs it indicates 
severely reduced cardiopulmonary reserve. In the most severe cases 
shock and arterial hypotension may be present. (ESC Task Force, 2008). 
Pleurisy and haemoptysis occur mostly in patients with a secondary 
pulmonary infarction, usually caused by smaller peripheral emboli. 
Symptoms including cough, palpitations and light-headedness may also 
result from pulmonary embolism. (Tapson, 2008).  
 
The results from routine testing done upon clinical presentation, including 
chest radiographs (CXR) and electrocardiogram (ECG) may also be non-
specific. CXR is useful in excluding other causes of dyspnoea and chest 
pain. ECG changes of right ventricular strain are usually only seen in 
severe forms of PE. These include inversion of T waves in leads V1-V4, a 
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QR pattern in lead V1, the classic S1Q3T3 and a right bundle branch block. 
(ESC Task Force, 2008).  
 
Clinical signs, symptoms and routine special investigations do not allow the 
exclusion or confirmation of VT. It should increase the index of suspicion, 
upon which further testing is needed. (ESC Task Force, 2008). 
 
1.2.2 Assessment of clinical probability 
 
Various clinical prediction rules (CPRs) have been developed to evaluate a 
patient‟s clinical probability of developing VT. The method that is most 
commonly used as a CPR is called the Wells score (Wells, Ginsberg, 
Anderson et al., 1998), including its variations, as outlined in Tables 1.2 
and 1.3 below. The Wells‟ Clinical Prediction model makes provision for 
both suspected PE and DVT. The specific tool used for calculating the 
clinical probability is not so important, but rather the fact that a careful 
assessment, taking risk factors for the development of VT, into 
consideration. (Tapson, 2008).The interpretation of the Wells Score for 
both DVT and PE is shown in Table 1.4. 
 
The aim of a CPR is to simplify complex clinical scenarios into subgroups 
of risk. It quantifies each element of the history, physical examination and 
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basic laboratory and radiology results and weights it toward the role it plays 
in the diagnosis. A CPR is especially useful in optimising the diagnosis, 
where the diagnosis is uncertain. (Hargett&Tapson, 2008) 
 
Table 1.2 The Wells’ Clinical Prediction Model for Suspected PE 
(Scarvelis&Wells, 2006) 
Clinical factor Points scored 
Clinically suspected DVT 3.0 
Alternative diagnosis less likely 
than PE 
3.0 
Tachycardia 1.5 
Immobilisation/surgery in previous 
four weeks 
1.5 
History of DVT or PE 1.5 
Hemoptysis 1.0 
Malignancy (treatment within 6 
months/ palliative) 
1.0 
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Table 1.3 The Wells’ Clinical Prediction Model for Suspected DVT 
(Hargett&Tapson, 2008) 
Clinical Finding Points Scored 
Active malignancy (ongoing 
treatment, or within the last 6 
months, or palliative) 
1 
Paralysis, paresis, or recent 
plaster immobilisation of the lower 
extremities 
1 
Recently bedridden for ≥ 3 days, 
or major surgery within the last 12 
weeks using general or regional 
anaesthesia 
1 
Local lower extremity tenderness 
along the deep venous system 
1 
Swollen thigh and calf 1 
Calf swelling ≥ 3 cm larger than 
asymptomatic leg (measured 10 
1 
 12 
cm below the tibial tuberosity) 
 
Clinical Finding Points Scored 
Unilateral pitting oedema of the 
symptomatic leg 
1 
Unilateral dilated superficial veins 
(non-varicose) of the symptomatic 
leg 
1 
Previously documented DVT 1 
Alternative diagnosis at least 
more likely that DVT 
-2 
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Table 1.4 Interpretation of the Wells Score (Hargett&Tapson, 2008) 
Scoring method Score Interpretation 
Wells Score for PE   
Traditional interpretation   
 > 6.0 High (59% based on pooled 
data) 
 2.0 - 6.0 Moderate (29% based on 
pooled data) 
 < 2.0 Low (15% based on pooled 
data) 
Alternate interpretation   
 > 4.0 PE likely. Consider contrast 
enhanced computed 
tomography (CTA) and D-
dimer testing .  
CTA -, D-dimer +: do 
ventilation perfusion scan. 
CTA -, D-dimer -: diagnosis 
excluded 
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Scoring method Score Interpretation 
 ≤  4.0 PE unlikely. Consider D-
dimer to rule out PE. 
 D-dimer -: PE ruled out 
 D-dimer +: Request 
CTA 
 CTA -: PE excluded 
CTA +: PE confirmed 
Wells Score for DVT   
 ≥ 2 DVT likely 
 ≤ 1 DVT unlikely 
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A complete history and thorough clinical examination should be done on all 
patients with a suspected VT. If VT remains a clinical probability, a formal 
pre-test probability assessment should be done, with a validated model 
(Hargett&Tapson, 2008). 
Should the results from the pre-test probability testing indicate a low or 
moderate clinical probability for VT; a D-dimer test should be done to 
assess the need for diagnostic imaging. Patients from this group with a 
positive D-dimer should all undergo chest imaging. (Hargett&Tapson, 2008). 
The D-dimer test has a low negative predictive value in patients with a high 
probability for PE, and therefore it should not be requested in this patient 
group. Patients with a high probability for PE should undergo imaging 
directly. (ESC Task Force, 2008). 
 
1.2.3 The D-dimer test 
 
The D-dimer test is widely available and used in al spheres of clinical 
practice to exclude clinically suspected DVT and PE (Tita-Nwa, Bos, Adjei 
et al., 2010). 
The D-dimer is a unique marker for a degradation product of fibrin created 
when cross-linked fibrin is broken down by plasmin. To further understand 
the concept of its formation, one has to understand the physiology behind 
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blood clot formation. A blood clot is formed when thrombin converts 
fibrinogen in plasma to fibrin monomers. (Adam,Key&Greenberg, 2009).  
Simultaneously thrombin activates factor XIII.  The activated factor XIIIa 
then cross-links with the fibrin monomers to form a cross-linked soluble 
fibrin polymer.  These soluble fibrin polymers will further cross-link to 
ultimately form an insoluble fibrin polymer.  Plasmin acts on both the 
soluble and insoluble fibrin polymer in a process of degradation.  This 
degradation process release a fibrin degradation product called the D-
dimer antigen.  The initial fragments are of a higher molecular weight, 
followed by a further plasmin-mediated degradation process that ultimately 
produces the terminal D-dimer-E-complex which contains the D-dimer 
antigen. (Adam et al., 2009) (See Figure 1.3 below).  
 
It is uncommon to detect circulating terminal fibrin degradation products in 
human plasma, whereas the soluble high molecular fragments (D-dimer 
antigens) can be measured in plasma. The D-dimer test measure an 
epitope on the degradation products of factor XIIIa, cross linked by fibrin.  
There are several methods of doing that.  All the tests use monoclonal 
antibodies that detect an epitope present in the factor XIIIa-cross linked 
fragment-D-domain of fibrin. Each monoclonal antibody, recognises a 
different epitope on the degradation product, thus different D-dimer tests 
have different specificities.  Every assay also has a different format, 
calibration standard and different instrumentation.  Therefore it is important 
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for an emergency practitioner (EP) to be familiar with the standards of the 
D-dimer assay that is used to produce the results, at the institution where 
he is practising.  Efforts have been made by the International Society of 
Thrombosis and Haemostasis Scientific Standardisation Subcommittee to 
standardise assay results, but due to differences in the D-dimer analyte, it 
has not been successful yet. (Adam et al., 2009). 
 
D-dimer values start rising the first day after the onset of symptoms of a VT, 
reaching a maximum 2-4 days after the onset of symptoms. Although levels 
drop thereafter a D-dimer test can remain positive for more than 12 days 
after the onset of symptoms (Goldin, Pasvolsky, Rogowski et al., 2011). 
 
The first D-dimer tests were performed through a latex agglutination 
process.  Latex beads were coated with the DD-3B6 antibody and added to 
the medium. When sufficient D-dimer antigen is present agglutination will 
be initiated. These early tests required personnel to visually report the 
degree of the agglutination process. Furthermore the test could only be 
performed in plasma, and only detected the D-dimer where plasmin has 
degraded the cross linked insoluble protein.  (Adam et al., 2009). 
Subsequently automated latex agglutination was developed that reported 
the rate at which antibody coated particles aggregated when in contact with 
D-dimer antigen.  These showed different specificities depending on if they 
were reacting with high or low molecular weight fibrin degradation products. 
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Another method the enzyme-linked-immuno-assay (ELISA) was initially 
developed for research purposes. The D-dimer antigen is captured on a 
plate, which is then followed by tagging the antigen with an antibody 
detection system.  The method is extremely sensitive, but was initially time 
consuming until it was gradually automated for clinical use.  Technological 
advances have led to the gold standard ELISA-based assays.  These use 
an enzyme-linked-fluorescent-assay (ELFA) in their endpoint detection. 
They have equivalent sensitivity to ELISA testing but can be performed 
faster and detect D-dimer antigen at even lower levels (between 0-1000 
µg/ml) (Adam et al., 2009).  
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Figure 1.3 Pathophysiology of clot formation (Modified from 
Wakai,Gleeson&Winter, 2003) 
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Other methods of D-dimer testing include immuno-filtration that can yield 
results within two minutes – a definite advantage in a clinical setting.  
These maintain a good sensitivity compared to ELISA testing. Apart from 
the above mentioned methods whole blood agglutination also exists.  
These are not as sensitive, but are fast and have a limited need for 
sophisticated laboratory equipment. (Adam et al., 2009). 
 
The laboratory from which the data for the study was obtained uses the 
Vidas D-dimer exclusion test.  It is an immuno-enzymatic elimination of 
fibrin degradation products in human serum using ELFA.  It is reported to 
have an overall sensitivity, regardless of pre-test probability of between 
98.4-100% and a specificity of between 34.2-41.3%. (Perrier, 2004).  It is 
advised by the manufacturer, that the test always be used in conjunction 
with the pre-test probability (ex. Wells score), for the optimal results. 
 
Each of the different tests has their own sensitivity and corresponding 
specificity.  A D-dimer test should at least have a moderately high 
sensitivity for it to be used safely as a negative predictive marker in the 
diagnostic algorithm. A positive D-dimer result should always be followed 
up by further confirmatory or exclusion tests. (Hargett&Tapson, 2008). 
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The ELISA and ELFA tests have a higher sensitivity than the whole blood 
agglutination test – 95% vs. 85%, but in return a lower specificity – 50% vs. 
70%(Adam et al., 2009).  The implication of this is that the first will yield 
more false positive results, making it an ideal screening test, but not a good 
confirmatory test.  Using the ELISA and ELFA, is ideal in a setting where a 
VT is expected, but once a positive result is obtained, further confirmatory 
tests are needed. Again, it emphasises the importance that the EP should 
be familiar with the properties and limitations of the D-dimer test used in the 
environment where he practices, in order to interpret it correctly. 
 
There are conditions that can lead to an increase in D-dimer value without 
a PE being present (false positive). These include advanced age, 
pregnancy, recent trauma or surgery, malignancies and the presence of 
haematomas and infections. (Wakai et al., 2003).  Unfortunately, patients 
presenting with PE often have these underlying conditions, predisposing 
them to its development. Clinical trials have demonstrated that the D-dimer 
test in isolation is not sufficient to make the diagnosis of PE (Kruip, Slob, 
Schijen et al., 2002).  The D-dimer should always be used as part of a 
clinical algorithm which also incorporates the pre-test probability for the 
condition. 
 
In a study done involving 3306 patients, it was found that a low probability 
for PE and a negative D-dimer test was effective in excluding PE.  During 
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the 3 month follow-up the incidence of thromboembolism was 0,5% (van 
Belle, Buller, Huisman et al., 2006).  In a study looking at patients with a 
high clinical probability for PE, the D-dimer test had a better negative 
predictive value than the Wells criteria, but the accuracy of the diagnosis 
was improved by using both together (Soderberg, Brohult, Jorfeldt et al., 
2009). A prospective study done by Kline on 2302 patients, showed that 
the post-test prevalence of PE among low-risk patients with negative D-
dimer test results were 0,7% (95% CI, 0,6-1,7) without using a clinical 
prediction tool (Kline, Runyon, Webb et al., 2006). Reviewing current 
literature shows that the D-dimer test does assist with the diagnosis of PE. 
It has a strong negative predictive value, but a positive D-dimer test should 
always be followed up with further confirmatory testing to reach the 
diagnosis of a VT. 
 
1.2.4 Differential diagnosis for a positive D-dimer test 
 
There are many conditions associated with fibrin formation, explaining the 
limited specificity of the D-dimer test. The formation and lysis of fibrin are 
part of the inflammatory response, acute phase response and a plays a 
role in the production of various systemic inflammatory mediators. (Wakai 
et al., 2003). Therefore a positive D-dimer test should always be viewed 
within the patient‟s clinical context, with the doctor carefully considering 
other diagnoses than VT (Table 1.5). 
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The increase of the D-dimer value in non-pathological conditions, like 
increased age, compromises the specificity of the D-dimer value as a tool 
to rule out DVT and PE in certain patient groups, like the elderly (Tita-Nwa 
et al., 2010).) 
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Table 1.5 Conditions leading to increased D-dimer values (Wakai et al., 
2003). 
Non-pathological Pathological 
 Cigarette smoking 
 Increasing age 
 Functional impairment 
 Race – black population 
 Pregnancy 
 Post-surgical 
 Trauma 
 Pre-eclampsia 
 Malignancy 
 Infection 
 Sickle cell disease 
 Disseminated intravascular 
coagulation 
 Arterial or venous thrombosis 
 Atrial fibrillation 
 Acute coronary syndromes 
 Stroke 
 Acute upper gastrointestinal 
haemorrhage 
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1.2.5 Imaging 
 
In the presence of a positive D-dimer test, the next step to confirm or 
exclude a VT is requesting the appropriate imaging technique. Most of the 
confirmation through imaging can either be completed or initiated within the 
ED. 
 
Although the CXR is usually normal it is useful to exclude other clinical 
diagnoses (ex. Pneumonia) and should be done as a baseline imaging test. 
During the later stages a CXR may show signs associated with a 
pulmonary infarct which include, a Westermark sign (dilatation of the 
pulmonary vessels and a sharp cut-off), a small pleural effusion, elevated 
diaphragm or atelectasis. (Ouellette, 2011). 
 
In patients where a PE is suspected CT angiography has become the gold 
standard imaging test. Ventilation-perfusion (V/Q) scanning is still utilised, 
but due to the high proportion of inconclusive results CT angiography is the 
preferred method, where available. Pulmonary angiography is a reliable 
test, but due to the fact that it is invasive it is usually reserved for cases 
where either the CT angiography or V/Q scanning is inconclusive. (ESC 
Task Force, 2008).  
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In 90% of patients a PE originates from a lower limb DVT and concomitant 
evidence of a DVT is usually found in 70% of patients with a PE. Due to the 
high sensitivity and specificity (>90%) of lower limb compression venous 
ultrasonography (CUS) it has largely replaced the need for venography to 
diagnose DVT. It can also be used to reduce false negative results from 
when using a single-detector CT for the diagnosis of PE. (ESC Task Force, 
2008).  
 
Different imaging modalities can be utilised to diagnose aortic dissection. 
These methods include: transthoracic /transoesophageal echocardiography 
(TTE /TEE), CT, magnetic resonance imaging (MRI), aortography and 
intravascular ultrasound. Each of them has their own advantages and 
disadvantages. TEE and TTE can be used in the ED or operating theatre 
with good accuracy, keeping the limitations in mind. CT is most often used. 
It has sensitivity of >90% and specificity of >85%, but is limited in 
diagnosing aortic regurgitation, intimal tears and subtle aortic dissection. 
MRI has the highest accuracy for detecting all forms of aortic dissection. Its 
use in the ED is mainly limited by availability. Aortography is not a 
technique utilised in the ED, but is the standard technique for guiding 
interventions in aortic dissection. (The Task Force on Aortic Dissection 
European Society of Cardiology., 2001). 
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Due to the costs and time needed to perform imaging, appropriate imaging 
studies, which support the findings on clinical history and examination, 
should be requested. 
 
1.3 Treatment of VT 
 
Although the EP will not be involved in the long-term treatment of patients 
with VT, they might initiate definitive treatment upon confirmation of the 
diagnosis in the ED. Therefore the EP should have a basic knowledge of 
the treatment modalities for VT. 
 
Patients with suspected DVT or PE should receive full anticoagulation with 
parenteral heparin, either low-molecular weight or unfractionated heparin. 
Diagnostic investigations should not delay empirical anticoagulant therapy. 
Heparin activates antithrombin III which slows the progression of a DVT 
and reduces pulmonary emboli. Although it does not dissolve the existing 
clot, it allows the fibrinolytic system to function unopposed . (Tapson, 2008). 
Oral anticoagulation in the form of warfarin can be started from day one. 
Heparin is continued for at least five days, until the international normalised 
ratio (INR) is between 2.0 to 3.0 (Tapson, 2008).   
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Despite outpatient anti-coagulation therapy with low-molecular weight 
heparin shown to be effective and safe in clinical trials, Spencer et al. found 
the morbidity and mortality of outpatient therapy to be higher than reported 
in clinical trials. They found that co-morbidities including cancer, severe 
infections and congestive heart failure were associated with poorer 
outcomes, making admission of these patients for therapy advisable. 
(Spencer, Goldberg, Lessard et al., 2010). 
 
Other treatment modalities include thrombolytic therapy and surgical care 
in the form of inferior vena cava (IVC) interruption or IVC filters. These are 
not always considered as standard therapy, but used in specific clinical 
situations. (Tapson, 2008). 
 
VT, especially PE is one of the major diagnostic problems in the ED, due to 
a combination of high incidence but with a non-specific clinical presentation. 
The 30-day mortality of PE has been reported to be around 7,2%, 
emphasising the importance of prompt diagnosis and treatment (Martinez 
Izquierdo, Pallas Villaronga, Clemente Rodriguez et al., 2010). 
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CHAPTER 2 
2.0 DIAGNOSIS AND TREATMENT OF VT IN THE ED 
2.1 Prevalence of a  positive D-dimer tests in the ED 
 
Corwin et al. (2009) reported a prevalence of 39% positive D-dimer tests in 
a population with a low clinical suspicion of VT. Kline et al. (2006) 
supported this figure in another study. They found a prevalence 29,9% 
(690/2302) in symptomatic patients evaluated for PE in the ED. 
 
In a study conducted in an American ED, a slightly higher prevalence of 
44% was found.  Out of the 44% of patients with a positive D-dimer test, PE 
was confirmed in 11% of these patients. The main aim of their study though, 
was to evaluate factors associated with a positive D-dimer test. Female sex, 
increasing age (from 4th to 5th decade), surgery, immobility and pregnancy 
were all strongly associated with a positive D-dimer. Active malignancy was 
associated with a positive D-dimer test, but not inactive malignancy. They 
also found that several factors associated with PE were not associated with 
a positive D-dimer test. These included smoking, obesity, thrombophilia 
and a family history of VT. (Kabrhel et al., 2010). 
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2.2 Epidemiology of VT in the ED population 
 
In a retrospective analysis of ED records in Australia the mean age of 
patients diagnosed with PE within the ED was 60,4 years. Among these 
patients 54,4% were female. Among the patients admitted from the ED 
there were 5,6% in-hospital deaths. (Jelinek, Ingarfield, Mountain et al., 
2009). 
 
A Spanish review found the mean age of patients to be older, at 70,8 years. 
They evaluated 30-day mortality which was found to be 7,2%. (Martinez 
Izquierdo et al., 2010) 
 
2.3 Current ED practice for clinical probability assessment of VT 
 
The ED is where patients with VT often present for the first time. As 
previously discussed these patients often present with non-specific signs 
and symptoms, which can be misleading to the EP. This combined with the 
fact that PE has a high mortality of up to 10% in the first hour, emphasises 
the importance of an accurate diagnostic strategy, which takes a CPR into 
account.(Ouellette, 2011). 
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A study conducted in the Netherlands, showed the importance of doing a 
CPR. They found that VT was diagnosed in 1,1% of patients with a low 
clinical probability of VT compared to 9,3% of patients with a high clinical 
probability of VT. This shows the importance of considering a CPR before 
D-dimer testing, both to minimise unnecessary testing and to ensure that 
the diagnosis of VT is not missed. (Gibson, Sohne, Gerdes et al., 2008). 
 
In a retrospective analysis of 100 randomly selected ED records, the 
documentation of a CPR was evaluated. Only records, in which VT was 
considered as a diagnosis, were included in the study (97 records). Out of 
the 97 records a CPR was documented in only 35 patient records. The 
authors concluded that CPR was not utilised in the majority of cases where 
VT was suspected. (Smith, Mensah, Sameer et al., 2008). 
 
2.4 Current ED practice for diagnostic testing and management of VT 
 
In another retrospective review the diagnostic process EPs followed in 
patients with both a low and high clinical suspicion for PE was evaluated. 
They found that in 42% of patients with a low clinical probability of PE and 
a positive D-dimer, there was an omission to request a CT. According to 
diagnostic protocol all these patients should have received a CT scan. 
They calculated that this caused a potential of a missed diagnosis of PE in 
12 patients. In the same publication they reported the discharge diagnoses 
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among the 605 (42%) of patients who did not receive a CT scan, but had a 
positive D-dimer. (Corwin, Donohoo, Partridge et al., 2009). Although most 
of these can also cause a rise in the D-dimer value, the consideration of the 
diagnosis alone does not exclude the possibility of a PE. 
 
Corwin et al. (2009) also recorded the discharge diagnoses in patients in 
whom a D-dimer test was done. An unspecified diagnosis described as 
other was considered in the majority of patients. Chest pain or dyspnoea 
not otherwise specified was the second most common diagnosis in this 
group, followed by chronic obstructive pulmonary disease or asthma. 
Pneumonia, congestive cardiac failure, cardiac arrhythmia, myocardial 
infarction, acute cholecystitis and pericarditis were the other diagnoses 
considered. 
 
In a similar review done by Smith et al. (2008) in Canadian EDs, 7 out of 12 
(58,33%) patients with a positive D-dimer test received a subsequent 
imaging test. There were 15 patients with a negative D-dimer test that 
received imaging unnecessarily. Among the 97 patients included in the 
study they found that management of 25% of patients were not according 
to established management protocols.   
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2.4 Rationale for the current study 
 
Published data on ED practices in the diagnosis and management of VT 
have shown a lack of utilisation of a CPR and treatment decisions in 
disagreement with established management protocols for VT. Currently, all 
published data on ED practices in the diagnosis and management of VT 
come from countries outside of South Africa. 
 
The D-dimer test is widely available within the South African ED 
environment and often utilised by EPs. The prevalence of a positive D-
dimer test within the South African ED is not known. It would be of value to 
know if this correlates with the prevalence found in publications from other 
countries, where the demographic characteristics of patients might differ.  
 
The limited time a patient spends in the ED provides a short, but critical 
window of opportunity for the EP to diagnose VT.  With the knowledge that 
the early diagnosis of VT within the ED environment can reduce VT 
mortality, it would be valuable to evaluate the current practice of South 
African EPs in the diagnosis and management of VT, in order to identify if a 
need exists for improvement of their current practice. The evaluation of the 
current practice will incorporate the utilisation of a CPR, the actions taken 
in reaction to a positive D-dimer test, including both diagnostic testing and 
treatment initiated within the ED. 
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Because resources are limited, doctors are forced to consider the 
diagnostic and management costs of patients. On the other hand doctors 
also strive to adhere to practices supported by evidence based medicine. 
This emphasises the importance of adhering to a diagnostic approach, 
which ensures accurate diagnosis of conditions without the overuse of 
resources. 
 
2.5 Aims of the current study 
 
The aims of this study are 
 To establish the prevalence of a positive D-dimer test in a South 
African private ED. 
 To document the differential diagnosis considered in patients with a 
positive D-dimer test. 
 To compare the management of patients with a positive D-dimer test in 
a private ED to published clinical management recommendations. 
 To establish the clinical utility of the Wells Score in patients with a 
positive D-dimer test.  
 To document the clinical outcome of patients with a positive D-dimer 
test within the private ED. 
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CHAPTER 3 
3.0 MATERIALS AND METHODS 
3.1 Study design 
 
This is a retrospective cross-sectional uncontrolled study that compared the 
management of patients with a positive D-dimer test, in a single private 
South African hospital ED, to international published ED management 
standards. 
 
3.2 Human research ethics clearance 
 
Permission to use the patient and laboratory records for this study was 
sought from the institutional protocol review committee prior to study 
initiation. As this was a retrospective analysis of patient records no patient 
informed consent form was required prior to data access. Permission to 
utilise the data was obtained from the management of Lancet laboratories 
and the hospital manager at Flora Clinic. Unconditional ethics approval was 
granted by the University of the Witwatersrand Human Research Ethics 
Committee, clearance certificate number M10449, which is included as 
appendix A of this dissertation.  
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3.3 Setting of the study 
 
The entire patient records analysed in the study was obtained from Flora 
Clinic ED situated in Johannesburg, Gauteng, South Africa. Flora clinic is a 
private hospital with a 24 hour ED facility, which manages both trauma and 
medical emergencies, for patients choosing to utilise private healthcare. 
Laboratory data was obtained from Lancet Laboratories, an independent 
South African National Accreditation System (SANAS) accredited 
laboratory, contracted to do all laboratory diagnostic tests on patients 
presenting to the Flora Clinic ED. 
 
3.4 Selection of patients for the study 
 
The study population included all patients who presented at the Flora Clinic 
ED, in whom a D-dimer test was done during the seven month study period, 
which was from 1 November 2008 to 31 May 2009. The study population 
included patients with medical as well as surgical conditions. 
 
Both male and female patients, above 18 years of age, were included in the 
study population. Patients below 18 years of age were excluded from the 
study, as most of the conditions associated with a raise in the D-dimer test 
do not occur frequently within the paediatric population. 
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3.5 Sample size calculation 
 
Sample size calculation was based on the desired precision of the primary 
outcome, which was the proportion of charts with documentation of the pre-
test probability scores and management of positive D-dimer tests against 
published protocols.  
 
Assuming that the ED visit documentation rate was approximately 75% we 
determined that we would need to review 63 charts to produce a 
confidence interval (CI) for our estimate of the primary outcome that would 
not be wider than 5%. The study sample was increased to 100 to allow for 
an unknown documentation rate.  
 
3.6 Data collection 
3.6.1. D-dimer test result  
 
All D-dimer test results requested on patients in the Flora Clinic ED from 1 
November 2008 up to 31 May 2009 were obtained from the Lancet 
laboratory.  Lancet laboratories use the Vidas D-dimer test method. It is an 
immuno-enzymatic elimination of fibrin degradation products in human 
serum, using ELFA.  It is reported to have an overall sensitivity, regardless 
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of pre-test probability of between 98.4-100% and a specificity of between 
34.2-41.3% (Perrier, 2004). These performance characteristics make it an 
excellent screening test. 
 
D-dimer test results were divided into positive or negative according to the 
Vidas test reference ranges established by Lancet laboratory. All results ≥ 
0,5 ug/ml were reported as positive. Results < 0.5 ug/ml was classified as 
negative. Results were entered into an excel spreadsheet. 
 
3.6.2. Clinical notes 
 
The clinical notes and special investigation report forms, present in the 
patient files of patients with positive D-dimer tests, during the defined study 
period were also reviewed. Should patient records be missing in patients 
where the laboratory results were available, the patients were still included 
in the study. In these instances, demographic data could still be obtained 
from the laboratory results and were included in the data analysis. Data 
analysis that depended on data captured from the clinical notes could not 
be obtained and therefore these patients‟ data were excluded from all 
analysis that relied on data from the patient records as source. 
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The management of these patients within the ED and special investigations 
requested in response to the positive D-dimer result were evaluated. The 
elements of the Wells Score noted in the clinical notes of emergency EPs 
working at Flora Clinic ED, in patients who had a positive D-dimer test, 
during the study period were also  recorded and the total percentage of 
Wells Score elements mentioned in the clinical notes was  calculated per 
element.  
 
Subsequently the outcomes of patients with a positive D-dimer test, within 
the ED were also determined. The clinical notes were evaluated to see 
which differential diagnosis was considered for each patient and which 
special investigations were requested within the ED. 
 
3.6.3. Data collection sheet 
 
The collected data were transferred onto a data collection sheet (Appendix 
B). To ensure patient confidentiality, the data sheet was anonymous with 
patient names and other personal identification details removed and 
replaced by a study number. All data sheets were kept separate from all 
the mentioned results for the purpose of analysis and reporting of data.   
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Reporting of data was done on all patients eligible for the study, as defined 
by the inclusion and exclusion criteria during the defined study period.  All 
data captured on the data collection sheets were inserted into 2X2 tables 
using excel spreadsheets.  
 
3.7 Statistical analysis 
 
Descriptive and inferential statistics were used to explore and analyse the 
data respectively.  Measures of central tendency (mean, median and mode) 
and measures of variability (standard deviation and range) were used to 
describe continuous variables. Frequency distribution tables were used to 
describe categorical variables. To compare pairs of categorical variables 
the Chi-Square and where appropriate the Fischer‟s exact test were used. 
The student‟s t-test was used to analyse pairs of a continuous variables.  
 
The 95% confidence intervals and standard deviation for all the results 
were calculated. Statistical significance was ascertained at the 5% level, at 
which level a p-value of less than 0.05 would show statistical significance. 
 
A biostatistician was consulted to assist with complex statistical analytical 
processes.  
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CHAPTER 4 
4.0 RESULTS 
4.1 Study population selection 
 
The results from the study population selection process are depicted 
graphically in Figure 4.1 below. Between 1 November 2008 and 31 May 
2009 there were 365 D-dimer tests requested in the Flora Clinic ED. 
Among these 220 (60%) of the results were negative and the balance 
positive (40%). One patient with a positive D-dimer test was below 18 years 
of age, and therefore excluded from the study. In 144 (99%) of patients with 
a positive D-dimer test, all the inclusion criteria were met.  Out of the 144 
patients who met the inclusion criteria 122 (85%) patient records were 
available for further data analysis. There were 22 (15%) patient records 
that could not be located at the time of the study, and as outlined in section 
3.6.2, these patients had to be excluded from data analysis which relied on 
the patient records as main source. Demographic data, available on the 
pathology reports could still be used for the 22 patients with missing patient 
records. 
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Figure 4.1 Study population selections 
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4.2 Study population demographics 
 
 The mean age of the 144 patients with positive D-dimer tests, who met the 
inclusion criteria, was 62 years with a range from 19-94 years. In the 
selected study population there was a slight predominance of males 
comprising 76 (53%) subjects. Patient records were analysed sequentially 
according to study number.  
  
4.3 Study population D-dimer values 
 
The prevalence of a positive D-dimer test among adult patients presenting 
in the Flora Clinic ED in whom a D-dimer test was requested, within the 
specified study period, was 39%. 
 
The D-dimer values of the study population, at the time of presentation in 
Flora ED, are shown in Table 4.1 below. The mean D-dimer value in the 
study population was 2,58 μg/ml with a range of 0,51-41,40 μg/ml. 
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Table 4.1 Study population D-dimer values 
Patient study 
number 
D-dimer value 
(ug/ml) 
Patient study 
number 
D-dimer 
value(ug/ml) 
1 1.59 73 1.39 
2 0.79 74 3.68 
3 6.15 75 2.15 
4 4.93 76 1.45 
5 1.47 77 0.71 
6 1.08 78 1.00 
7 1.67 79 1.35 
8 0.67 80 1.24 
9 0.59 81 1.35 
10 0.83 82 1.44 
11 0.64 83 0.55 
12 1.23 84 0.52 
13 1.01 85 0.74 
14 1.10 86 9.09 
15 1.25 87 0.61 
16 3.02 88 10.00 
17 2.38 89 0.98 
18 0.81 90 4.48 
19 1.75 91 28.65 
20 0.53 92 1.15 
21 8.84 93 1.46 
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Patient study 
number 
D-dimer value 
(ug/ml) 
Patient study 
number 
D-dimer 
value(ug/ml) 
22 1.38 94 1.50 
23 1.12 95 4.10 
24 1.12 96 0.68 
25 1.07 97 2.20 
26 1.08 98 0.98 
27 1.66 99 0.77 
28 1.40 100 0.69 
29 0.87 101 0.57 
30 0.74 102 1.79 
31 0.59 103 0.53 
32 0.58 104 1.85 
33 5.19 105 0.61 
34 1.59 106 0.55 
35 1.40 107 3.91 
36 1.21 108 0.75 
37 1.59 109 0.53 
38 6.85 110 0.82 
39 0.57 111 0.84 
40 1.58 112 0.62 
41 0.70 113 1.82 
42 0.57 114 1.12 
43 1.72 115 7.91 
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Patient study 
number 
D-dimer value 
(ug/ml) 
Patient study 
number 
D-dimer 
value(ug/ml) 
44 1.03 116 2.49 
45 2.36 117 0.53 
46 0.58 118 2.67 
47 0.52 119 4.90 
48 0.98 120 5.61 
49 0.61 121 1.14 
50 0.69 123 1.80 
51 1.49 124 4.19 
52 2.07 125 3.37 
53 1.73 126 6.03 
54 1.11 127 0.90 
55 8.42 128 0.66 
56 1.63 129 1.09 
57 0.73 130 6.54 
58 14.70 131 0.70 
59 0.60 132 1.07 
60 6.85 133 2.88 
61 2.03 134 5.14 
62 0.81 135 6.06 
63 0.63 136 0.55 
64 4.54 137 41.40 
65 1.70 138 1.74 
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Patient study 
number 
D-dimer value 
(ug/ml) 
Patient study 
number 
D-dimer 
value(ug/ml) 
66 0.51 139 0.71 
67 2.31 140 8.27 
68 0.96 141 0.80 
69 0.56 142 2.71 
70 8.00 143 1.43 
71 0.77 144 1.05 
72 1.20 145 5.73 
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4.4 Differential diagnoses in patients with a positive D-dimer test 
 
There were 163 differential diagnoses entries in the clinical notes.  In ten 
(7%) of the patient records no differential diagnosis was documented. 
There were on average 1,13 differential diagnoses per patient record 
documented. 
 
The differential diagnoses were categorised according to the main organ 
system involved, as shown in Figure 4.2. The actual differential diagnoses 
and their frequencies are shown in Table 4.2. In 36 (25%) of the patient 
records, VT was considered as one of the differential diagnoses and it 
constituted 22% of all the differential diagnoses considered. Among the 
other diagnoses considered acute myocardial infarction (12 patients) was 
the most frequent, with respiratory tract infection, including pneumonia 
second (10 patients) (Table 4.2b). 
 
 Of the 163 entries 61% (99 entries) were of conditions that could be 
associated with an increased D-dimer titre. These constituted 18 out of the 
48 different differential diagnoses considered (38%).  
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Figure 4.2 Categorisation of the differential diagnoses 
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Table 4.2 (a) Listing of differential diagnoses 
 
System Category Frequency 
      
Neurological  31 
  Cerebrovascular incident 8 
  Seizure/Epilepsy 7 
  Transient ishaemic attack 4 
  Anxiety 3 
  Syncope 3 
  Dizziness 2 
  Intracranial bleed 2 
  Confusion 1 
  Hemorraghic brain metastases 1 
   
Cardiovascular  68 
  VT 36 
  Acute myocardial infarction 12 
  Unstable angina 5 
  Hypertension 4 
  Atrial flutter/atrial fibrillation 2 
  Congestive cardiac failure 2 
  Hypovolaemic/septic shock 2 
  Arterial occlusion of foot 1 
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  Dissecting aortic aneurysm 1 
  Heartblock 1 
  Venous stasis leg 1 
  Ventricular tacycardia 1 
      
Gastrointestinal  20 
  Gastritis/Peptic ulcer 5 
  Hiatus hernia/dyspepsia 4 
  Oesophagitis 4 
  Cholecystitis/gallstones 2 
  Dehydration 2 
  Partial bowel obstruction 1 
  Strangulated hernia 1 
  Sub-acute abdomen 1 
      
Respiratory  18 
  Pneumonia/Respiratory tract 
infection 
10 
  Dyspnea/pulmonary edema 2 
  Unspecified chest pain/pleurisy 2 
  Bronchitis 1 
  Bronchospasm 1 
  Pulmonary collapse 1 
  Sinusitis 1 
 52 
      
Renal  6 
  Pyelonephritis/urinary tract 
infection 
5 
  Renal failure 1 
      
Muskuloskeletal  6 
  Cellulitis/soft tissue infection 3 
  Baker's cyst 1 
  Lumbar disc prolapse 1 
  Thoracic spine arthritis 1 
      
Other  14 
  Injury/Trauma 5 
  Cancer 3 
  Hyperglycaemia 3 
  Polypharmacy 1 
  Hypoglycaemia 1 
  Iron deficiency anemia 1 
Total   163 
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Table 4.2(b) Most frequent differential diagnoses considered 
Differential diagnosis Frequency 
VT 36 
Acute myocardial infarction 12 
Pneumonia/Respiratory tract infection 10 
Cerebrovascular incident 8 
Seizure/Epilepsy 7 
Pyelonephritis/urinary tract infection 5 
Injury/Trauma 5 
Unstable angina 5 
Transient ishaemic attack 4 
Hypertension 4 
Hiatus hernia/dyspepsia 4 
Oesophagitis 4 
 
4.5 Utility of the Wells Score in patients with a positive D-dimer test 
 
The patient records were evaluated for any entry, by the attending doctor in 
ED, that relates to the criteria on either the Wells Score for DVT or PE (see 
Table 1.2 and 1.3). The presence of each element of the Wells score was 
evaluated, regardless of the value allocated to that specific element or the 
differential diagnosis considered. 
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The number of entries per Wells Score element is shown in Table 4.3 and 
4.4 for PE and DVT respectively. In 79% (113 entries) of the patient 
records an alternative diagnosis less likely than PE was considered, 
making it the most frequent element from the Wells Score for PE 
documented. Haemoptysis was only documented in 1 (0,69%) patient 
record, making it the least documented element from the Wells Score for 
PE. 
 
There were 312 entries across the 144 patients included that related to one 
of the Wells Score elements for PE, with an average of 2,17 entries per 
record. The highest amount of elements documented per record was 6, 
while some of the records had no entries. 
 
On the Wells Score for DVT an alternative diagnosis more likely than DVT 
was considered in 106 (74%) patient records, being the element 
documented most frequently. The element from the Wells Score for DVT 
documented the least was unilateral pitting oedema of the symptomatic leg, 
with only 3 (2%) entries. There were 250 entries in the 122 that could be 
linked to the Wells Score elements for DVT, with an average of 1,74 entries 
per record. The highest number of elements documented per record was 
also 6, with 0 entries being the lowest. 
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In none of the records where VT was considered as a diagnosis could a 
formal documentation of any pre-test probability evaluation be found and 
therefore there weren‟t any records where all elements were considered 
once the diagnosis of VT was considered. 
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Table 4.3 Wells Score elements for PE documented 
Clinical factor Clinical note 
entries 
% of clinical notes 
in which mentioned 
Clinically suspected DVT 14 9 
Alternative diagnosis less likely than 
PE 113 79 
Tachycardia 108 75 
Immobilisation/surgery in previous four 
weeks 51 35 
History of DVT or PE 12 8 
Haemoptysis 1 0.69 
Malignancy (treatment within 6 
months/ palliative) 13 9 
Total entries 312   
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Table 4.4 Wells Score elements for DVT documented 
Clinical factor 
Clinical note 
entries 
% of clinical notes 
in which mentioned 
Active malignancy 13 9 
Paralysis, paresis or recent plaster 
immobilisation lower extremities 41 29 
Recently bedridden ≥ 3 days, or major 
surgery within last 12 weeks 42 29 
Local lower extremity tenderness 
along deep venous system 10 7 
Swollen thigh and calf 10 7 
Calf swelling ≥ 3 cm larger than 
asymptomatic leg 4 3 
Unilateral pitting oedema of the 
symptomatic leg 3 2 
Unilateral dilated superficial veins 
symptomatic leg 14 10 
Previously documented DVT 7 5 
Alternative diagnosis at least more 
likely that DVT 106 74 
Total entries 250 
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4.6 Management of patients with a positive D-dimer test 
 
The management of patients in the Flora Clinic ED was evaluated through 
looking at both special investigations requested in the ED and treatment 
initiated in the ED. These were compared to international published 
protocols for the management of both DVT and PE (see Figures 4.3 and 
4.4). The decision, if the special investigations and treatment compared to 
international published protocols, was based on clinical judgement and if 
the outcome of the special investigations was taken into account to decide 
whether the treatment given was according to published protocols. 
 
There were 16 special investigations requested according to published 
protocols, in 15 different patient records. The details of the special 
investigations requested are reflected in Table 4.5 below. In 10 (63%) the 
results confirmed a VT, through the results of 5 (31%) tests VT could be 
excluded and in one (6%) case the results were not available. 
 
In 15% (22 patient records) no treatment was initiated. In the remaining 100 
records, where treatment was documented, 15 (10% of total patient records 
evaluated) were according to published protocols. The detail of all the 
treatment given in the ED is given in Table 4.6 below. There were a total of 
40 different treatments given, with intravenous (IV) fluid therapy being the 
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treatment given most commonly, in 44 (31%) of patients. Intravenous 
paracetamol, given in 23 (16%), was the pain relief given most frequently. 
There were an average of 1,53 different treatment entries per patient 
record. 
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Table 4.5 Special investigations requested in Flora Clinic ED for 
patient with positive D-dimers 
  Number As % of patient records 
Investigations mentioned     
Repeat D-dimer 1 0.69 
Abdominal sonar 1 0.69 
VQ scan 1 0.69 
CT angiogram chest 1 0.69 
CT chest 3 2 
Duplex doppler 6 5 
CT brain 1 0.69 
Chest X-ray 1 0.69 
Venogram 1 0.69 
Total 16 11 
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Table 4.6 Different treatments initiated in Flora Clinic ED in patients 
with positive D-dimers 
Category Treatment strategy in ED 
Number 
recorded 
Pain relief    
  Paracetemol IV (Perfalgan) 23 
  Tramadol IV 5 
  Parecoxib IV 8 
  Pethidine IV 1 
  Lentogesic® p.o 1 
  Synap Forte® p.o 2 
  Ketorolac IV 1 
  Myprodol® p.o 1  
Antispasmodics    
  Hyoscine IV 3 
      
Antibiotics  8 
      
Anticoagulation/fibrinolytics    
  Streptokinase IV 1 
  Enoxaparin 9 
  Aspirin p.o 17 
  Warfarin p.o 2 
  Heparin IV 1 
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Category Treatment strategy in ED 
Number 
recorded 
Ventilation/Respiratory 
support    
  Intubation 3 
  Oxygen per face mask 10 
  Nebulisations: Ipratropium/Salbutamol 1 
Electrolytes/Metabolic/Fluid    
  Potassium 1 
  IV fluid therapy 44 
  Insulin 2 
Sedatives    
  Hydroxyzine p.o 1 
  Lorasepam IV  5 
  Diazepam IV 1 
  Midazolam IV 2 
  Promethazine 1 
Anti-arrhythmic    
  Amiodarone IV 1 
Antacid therapy    
  Esomeprazole IV 18 
Anti-emetics    
  Metoclopramide IV 9 
  Procholrperazine IV 1 
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Category Treatment strategy in ED 
Number 
recorded 
  Odansetron IV 1 
Anti-epileptics    
  Phenytoin IV 1 
Corticosteroids    
  Hydrocortisone IV 1 
  Decadron IV 1 
Diuretics    
  Furosemide IV 2 
Other    
  Transfer to other facility 2 
  PE excluded 1 
  Repeat D-dimer 2 
  TNT 7 
  Ice packs   
  Compression bag 1 
  Elevation of leg 1 
  NG Tube 1 
No treatment   18 
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4.7 Outcome of patients with a positive D-dimer test in the ED 
 
The final outcome of treatment in the ED is reflected in Figure 4.3 below. 
The majority (55%) of patients were admitted to hospital for further 
specialist treatment. Among the outcomes 9 (6%) patients did not fall into a 
specific outcome category. The details of the other outcomes are given in 
Table 4.7 below. 
 
In 23 (16%) of the patient record a recording could be found of the 
procedures planned after discharge from the ED. Out of the 23 records, 
three had recorded the outcome of these clinical tests or procedures 
conducted post ED discharge. The details of these procedures and 
outcomes are shown in Table 4.8 below.
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Outcomes in the ED
8%
56%
15%
6%
15%
Discharge with specialist referral Admission with specialist referral
Discharge without specialist referral Other
Missing patient outcomes
 
Figure 4.3 Outcomes in the ED 
 
Table 4.7 Detail of ED outcomes grouped under “Other” 
Detail of other outcomes Number 
Follow up in the ED for re-evaluation 2 
Telephonic consultation with specialist 5 
Venogram booked as out patient 1 
Referral to another hospital due to financial reasons 1 
Total 9 
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Table 4.8 Procedures and outcomes post ED 
Outcome in ED 
Details of clinical procedures 
planned post ED Outcome 
Admitted with specialist referral 
Admitted for ventilation post 
intubation unknown 
Admitted with specialist referral 
Admitted for intensive care 
monitoring unknown 
Admitted with specialist referral 
Admitted to intensive care for 
repeat blood tests and 
isosorbide dinitrate infusion unknown 
Admitted with specialist referral 
Admitted work-up and 
confirmation of pulmonary 
embolus diagnosis unknown 
Discharged without specialist 
referral 
VQ scan done in casualty - PE 
excluded 
PE 
excluded 
Admitted with specialist referral Admit for repeat D-dimer test unknown 
Discharged without specialist 
referral Spiral CT chest was done unknown 
Admitted with specialist referral Intensive care observation unknown 
Admitted with specialist referral For intensive care monitoring unknown 
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Outcome in ED Details of clinical procedures 
planned post ED 
Outcome 
Follow-up for in ED for re-
evaluation Venogram unknown 
Telephonic consultation with 
specialist Spiral CT chest Normal 
Admitted with specialist referral 
Admitted for pain relief, surgical 
consultation unknown 
Discharged with specialist 
referral 
To omit Warfarin tablet, repeat 
PI in 2 days unknown 
Admitted with specialist referral 
To high care on an insulin 
sliding scale unknown 
Admitted with specialist referral 
Admit and place nasogastric 
tube unknown 
Referral to another hospital due 
to financial reasons 
For transfer and specialist 
treatment at state hospital unknown 
Admitted with specialist referral 
Admitted and CT scan 
performed 
Dissecting 
aortic 
aneurysm 
diagnosed 
Discharged with specialist 
referral Follow up with cardiologist unknown 
Admitted with specialist referral 
Admitted to high care for 
observation unknown 
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Outcome in ED 
Details of clinical procedures 
planned post ED Outcome 
Admitted with specialist referral 
For CT scan chest, 
administration of low molecular 
weight heparin unknown 
Discharged with specialist 
referral For stress ECG unknown 
Admitted with specialist referral For IV antibiotics unknown 
Admitted with specialist referral For repeat D-dimer unknown 
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CHAPTER 5 
5.0 DISCUSSION AND CONCLUSION 
5.1 Demographic data 
 
This study provides demographic data on patients with a positive D-dimer 
test, no current publications mentioned demographic characteristics in this 
subset of  patients, which makes this data unique. The mean age of 62 
years of patients with a positive D-dimer test, in this cohort, is much higher 
than values reported by for example Kline et al. (2006), who reported a 
mean age of 44,7 years among patients in whom a D-dimer test was 
requested in the ED. This would support the data which stated that the 
incidence of a positive D-dimer test increases with age (Harper, Theakston, 
Ahmed et al., 2007).  Although this possibility exists within this cohort, the 
demographics of patients with a negative D-dimer test were not evaluated, 
so this could not be confirmed. Among the 144 patients with a positive D-
dimer test, no association could be found between the actual D-dimer value 
and the age of the patient (P=0,22). 
 
There were fewer females than males with a positive D-dimer test (47 vs. 
53%). Although more males presented with a positive D-dimer test, no 
statistical gender difference could be found between actual D-dimer values 
once the D-dimer was positive (p=0.98). No published data could be found, 
to evaluate if this trend also exists in other studies. 
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5.2 Prevalence and predictors of a positive D-dimer test 
 
The positive D-dimer prevalence of 39% compares to data published by 
Corwin et al. (2009) of 39%, evaluating the prevalence in an American ED.  
The prevalence was lower in another American publication which found 
that 29,9% of patients had a positive D-dimer test (Kline et al., 2006). 
 
Although the main objective of this audit was not to find associated factors 
with positive D-dimer results we could test the association between the D-
dimer value and available outcome and demographics. No association 
could be found between age or sex and how high the D-dimer value was. 
The only statistically significant association was between the D-dimer value 
and admission rates (p=0.02). The higher the D-dimer value, the more 
likely the EP was to admit the patient for further work-up and treatment. 
This differs from an evaluation by Kabhrel et al. (2010) which found multiple 
factors associated with a positive D-dimer test. 
 
5.3 Differential diagnoses considered in the ED 
 
The recording of the differential diagnoses in the majority of the clinical 
notes were made before the D-dimer test was either requested or the 
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results available. Thus in this study the differential was based on the 
clinical presentation of the patient alone. Keeping in mind that the 
differential, thus should have been based on a clinical probability 
assessment for VT, it was surprising to find that in only 25% of patient files 
VT was considered as a motivation for requesting a D-dimer test, as part of 
the diagnostic work-up. There were a substantial amount of other 
differentials considered (61% of differential entries) that could also be 
associated with a positive D-dimer test, but these in themselves could not 
serve as a motivation to request the D-dimer test, and should it be 
requested and found positive it should still be followed by appropriate 
imaging tests. 
 
5.4 Utility of the Wells Score 
 
 
Although the elements of the Wells Score were present in all the clinical 
records evaluated in this study, none of the clinical notes had a formal CPR 
evaluation recorded. This could be explained by various reasons, including 
calculation of a CPR by the EP without formal recording, or a lack of 
emphasis and awareness of the importance of CPR evaluation. The Flora 
Clinic ED is not linked to an academic centre, and being responsible for 
their own continued medical education, EPs practising here are not all 
exposed to an academic environment in which up-to-date information on 
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patient treatment and management is distributed frequently. The results 
from this cohort are in contrast to findings by Corwin et al. (2008), who 
found that 36% of records from EPs considering VT as a diagnosis 
contained a formal CPR recording.  
 
In view of the non-specific nature of VT presentation and the difference 
between the incidences of VT in patients with a low versus a high clinical 
probability for VT (Gibson et al., 2008), the lack of CPR recording is 
alarming. The danger of under-diagnosis and maltreatment is increased. 
The assessment of a pre-test probability does not need the utilisation of 
extra recources and streamlines diagnostic and treatment decisions. 
Awareness, improved utilisation and recording of a CPR is needed among 
EPs practising  in the Flora Clinic ED, to ensure appropriate management 
of patients with a positive D-dimer test result. 
 
5.5 Management of patients in the ED 
 
According to published international protocol all patients with a positive D-
dimer test and suspected VT should undergo either CT imaging of the 
chest or limb ultrasonography, depending if the diagnosis of PE or DVT is 
considered. Among the patients in Flora Clinic ED 11% received a special 
investigation according to treatment protocol. These included other 
diagnostic modalities (ex. Chest X-ray), apart from a CT scan, which are 
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also within diagnostic and treatment protocols. Corwin et al. (2009) only 
evaluated patients with a possible PE. They determined that 58% of 
patients with a positive D-dimer test received a CT scan. For the purpose of 
comparison, only the % of patients who received chest imaging (3%) were 
compared to the data  from the study done by Corwin et al. (2009). A 
difference of 54% was found between the % of chest imaging requested 
among EPs in the Corwin et al. (2009) publication and EPs at Flora Clinic. 
This has reached a statistical significance with a p-value of < 0.0001. 
Patient numbers in our study was much smaller and conducted over a 
shorter period of time, which could have had an influence on the results, 
but both studies were done in a single centre. 
 
The 15% of patients where no treatment was initiated, could not be 
compared to any trend in published data, but might point to ignorance and 
a lack of understanding about the implications of a positive D-dimer test. 
Among patients in the Flora Clinic ED, only 10% of patients received 
treatment according to published treatment protocol, highlighting that 
education is needed among these EPs concerning patient management of 
suspected VT. This is much lower than Corwin et al. (2009) who 
established that 75% of patients in their study were managed according to 
treatment protocol.  
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Not only do the EPs at Flora Clinic not record utilisation of a CPR, but once 
a positive D-dimer result is obtained it does not prompt appropriate 
diagnostic testing according to established protocols. The omission of 
utilising a CPR, could lead to unnecessary and random D-dimer test 
requests. Once a test is just requested randomly without clinical motivation 
it could lead to ignorance of the implications of such a test result. This 
could explain why the majority of EPs did not record appropriate action in 
response to the positive D-dimer test.  
 
5.6 Patient outcome in the ED 
 
Despite the lack of management according to published treatment 
protocols for VT the majority of patients (55%) with a positive D-dimer test 
were still admitted to hospital and referred for specialist treatment. As 
previously discussed the association was even stronger between 
admission and a higher D-dimer value. This might indicate that the EPs 
were at least considering the positive D-dimer test to be of enough 
importance for further work-up, that the positive D-dimer test could have 
accidentally been associated with other conditions that prompted admission 
or that they admit patients out of a fear of litigation.  
 
Although patients with a positive D-dimer test was more likely to be 
admitted it must be highlighted that this still does not ensure the diagnosis 
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or exclusion of VT and does not support clinical practice in the best interest 
of the patient. A delay in the diagnosis of VT, leads to a delay in the 
initiation of life-saving treatment with a possible effect of patient mortality 
and morbidity. 
 
5.7 Limitations of the study 
 
 Due to limited access to clinical notes and laboratory results the study 
could only be conducted over a 28 week  period. Therefore the study 
sample was small and no conclusion could be made about the trend 
the data follows over a long period of time. 
 This study was conducted at a single centre, results might not be 
representative of patients seen in the rest of South Africa and therefore 
not be generalised. 
  There were 22 clinical notes that could not be found in the patient files. 
Only demographic data and D-dimer values were available for these 
patients. They had to be excluded from all data analyses beyond that 
point. The absence of data from these 22 patients could have had an 
influence on the overall results found in the study. 
 The differential diagnosis from one record could not be included due to 
illegibility of that entry in the clinical notes. 
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 Due to the retrospective nature of the study and the reliance on patient 
records for information, any outcomes or decisions that were not 
recorded in the notes could not be utilised as evidence. 
 In most cases the patients were discharged from the ED before a final 
diagnosis was made. Therefore the final outcome of most of the 
patients was limited, not excluding the possibility that the diagnosis of 
VT could still be made. 
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5.8 CONCLUSION 
 
The prevalence of a positive D-dimer test in patients presenting at Flora 
Clinic ED, of 39%, correlates with that found in some other publications. 
There was no formal evaluation of a pre-test probability in any of the 
clinical notes, in addition only 10% of patients received treatment 
according to published treatment protocols. This suggests that the 
assessment of pre-test probability is not done in a formalised manner and 
that a positive D-dimer test is either misinterpreted or that knowledge gaps 
exist among the EPs regarding the correct management of a positive D-
dimer test. The study served in identifying the current trend of practice 
among EPs in the South African environment. Further studies evaluating 
the reasons for and methods to improve the under-utilisation of both CPRs 
and established treatment protocols will be useful. 
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APPENDIX A: ETHICS CLEARANCE CERTIFICATE 
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APPENDIX B: DATA COLLECTION SHEET 
 
Patient number: 
 
 
Demographic data: 
Age (years)  
Sex 
(male/female) 
 
 
Inclusion criteria present: 
The following criteria have to be present (mark with an X): 
 Yes No 
Presented to Flora Clinic Emergency 
Department 
  
Presenting between November 2008 and 
May 2009. 
  
Patient ≥ 18 years of age   
Positive D-dimer test recorded   
Value of D-dimer test   
 
The answer to all of the above should be yes for the patient to be included 
Total of inclusion criteria met:  
 80 
Yes No 
  
 
 
Elements of the Wells score present in the clinical notes: 
Wells Score in suspected PE: 
 
 Considered  
In clinical notes 
(yes/no) 
Clinically suspected DVT (as mentioned in clinical notes)  
Alternative diagnosis less likely than PE (as interpreted 
by investigator or mentioned in the notes) 
 
Tachycardia  
Immobilization/surgery in previous four weeks  
History of DVT or PE  
Haemoptysis  
Malignancy (treatment within 6 months/ palliative)  
Total of elements mentioned in patient score   
 
Wells Score in suspected DVT: 
 Considered in 
clinical notes Y 
(yes) or N (no) 
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Active malignancy (on-going treatment or within last 6 
months or palliative) 
 
Paralysis, paresis or recent plaster immobilisation of the 
lower extremities 
 
Recently bedridden for ≥ 3 days or major surgery within 
the last 12 weeks using general anaesthesia 
 
Local lower extremity tenderness along the deep 
venous system 
 
Swollen  thigh and calf  
Calf swelling  ≥ 3 cm larger than asymptomatic leg   
Unilateral dilated superficial veins of symptomatic leg 
(non-varicose) 
 
Unilateral pitting oedema of symptomatic leg  
Previously documented DVT  
Alternative diagnosis more likely than DVT considered  
 
 
Differential diagnosis: 
Has there been any response documented in reaction to the positive D-dimer 
test? 
 
Yes  
No  
If the answer is yes: 
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Was the diagnosis of VT (PE or DVT) considered by the attending doctor in 
the emergency department (mark with an X)? 
Yes  
No  
 
 
List other differential diagnosis considered by the attending doctor in the 
emergency department   (in the order mentioned in the notes): 
1.  
2.  
3.  
4.  
5.  
 
Patient outcome in the ED: 
Was any treatment initiated in response to the positive D-dimer test? 
Yes No 
  
 
If the answer to the question is yes specify the treatment given: 
1.  
2.  
3.  
4.  
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5.  
 
Action plan post ED visit planned by the EP in response to the positive D-
dimer test: 
EP‟s action Yes/No/Unsure 
No further action upon positive D-
dimer result 
 
Specialist referral 
 
 
Patient admitted  
Other: Specify 
1. 
2. 
3. 
 
 
Was the action plan post referral or admission documented? 
Yes No 
  
 
If the answer to the previous question was yes specify the action plan: 
--------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------- 
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Special investigations requested EP in response to the positive D-dimer test: 
Were any further special investigations requested? 
Yes No 
  
If the answer is yes specify the following: 
Test requested Outcome 
1.  
2.  
3.  
 
 85 
 
REFERENCES 
 
 
Adam, S.S., Key, N.S. &Greenberg, C.S. 2009. D-dimer antigen: current 
concepts and future prospects. Blood,vol. 113,pp. 2878-2887. 
Bulger, C., Jacobs, C. &Patel, N. 2004. Epidemiology of acute deep vein 
thrombosis. Tech Vasc Interv Radiol,vol. 7,pp. 50-54. 
Corwin, M.T., Donohoo, J.H., Partridge, R., et al. 2009. Do emergency 
physicians use serum D-dimer effectively to determine the need for CT 
when evaluating patients for pulmonary embolism? Review of 5,344 
consecutive patients. Am J Roentgenol,vol. 192,pp. 1319-1323. 
Eichinger, S., Heinze, G., Jandeck, L., et al. 2010. Risk assessment of 
recurrence in patients with unprovoked deep vein thrombosis or 
pulmonary embolism. The Vienna prediction model. Circulation,vol. 
121,pp. 1630-1636. 
Gibson, N.S., Sohne, M., Gerdes, V.E., et al. 2008. The importance of clinical 
probability assessment in interpreting a normal D-dimer in patients with 
suspected pulmonary embolism. Chest,vol. 134,pp. 789-793. 
Goldhaber, S.Z., Visani, L. &De Rosa, M. 1999. Acute pulmonary embolism: 
clinical outcomes in the International Cooperative Pulmonary Embolism 
Registry (ICOPER). Lancet,vol. 353,pp. 1386-1389. 
Goldin, Y., Pasvolsky, O., Rogowski, O., et al. 2011. The diagnostic yield of D-
dimer in relation to time from symptom onset in patients evaluated for 
 86 
venous thromboemolism in the emergency medicine department. J 
Thromb Thrombolysis,vol. 31,pp. 1-5. 
Hansson, P.O., Welin, L., Tibblin, G., et al. 1997. Deep vein thrombosis and 
pulmonary embolism in the general population. 'The study of men born 
in 1913' 
Arch Intern Med,vol. 157,pp. 1665-1670. 
Hargett, W.C. &Tapson, V.F. 2008. Clinical probability and D-dimer testing: 
How should we use them in clinical practice? Sem Resp Crit Care 
M,vol. 29,pp. 15-24. 
Harper, P.L., Theakston, E., Ahmed, J., et al. 2007. D-dimer concentration 
increases with age reducing the clinical value of the D-dimer assay in 
the elderly. Int Med J,vol. 37,pp. 607-613. 
Jelinek, G.A., Ingarfield, S.L., Mountain, D., et al. 2009. Emergency 
department diagnosis of pulmonary embolism is associated with 
significantly reduced mortality: a linked data population study. EMA,vol. 
21,pp. 269-276. 
Kabrhel, C., Courtney, M., Camargo, C.A., et al. 2010. Factors associated 
with positive D-dimer results in patients evaluated for pulmonary 
embolism. Acad Emerg Med,vol. 17,pp. 589-597. 
Kline, J.A., Runyon, M.S., Webb, W.B., et al. 2006. Prospective study of the 
diagnostic accuracy of the simplify D-dimer assay for pulmonary 
embolism in emergency department patients. Chest,vol. 129,pp. 1417-
1423. 
Kruip, M.J., Slob, M.J., Schijen, J.H., et al. 2002. Use of a clinical decision rule 
in combination with D-dimer concentration in diagnostic workup of 
 87 
patients with suspected pulmonary embolism: a prospective 
management study. Arch Intern Med,vol. 162,pp. 1631-1635. 
Martinez Izquierdo, M.T., Pallas Villaronga, O., Clemente Rodriguez, C., et al. 
2010. Clinical presentation of pulmonary thromboembolism in an 
emergency department: comparison with previous studies. 
Emergencias,vol. 22,pp. 113-116. 
Michiels, J.J., Gadisseur, A., van der Planken, M., et al. 2006. Different 
accuracies of rapid enzyme-linked immunosorbent, turbidimetric, and 
agglutination D-dimer assays for thrombosis exclusion: impact on 
diagnostic work-ups of outpatients with suspected deep vein 
thrombosis and pulmonary embolism. Semin Thromb Hemost vol. 
32,pp. 678-693. 
Ouellette, D. 2011. Pulmonary Embolism.   Retrieved 25 July, 2011, from 
http://emedicine.medscape.com/article/300901. 
Perrier, A. 2004. Diagnosing pulmonary embolism in outpatients with clinical 
assessment, D-dimer measurement, venous ultrasound, and helical 
computed tomography: a multicenter management sutdy. Am J Med,vol. 
2004,pp. 291-299. 
Scarvelis, D. &Wells, P.S. 2006. Diagnosis and treatment of deep-vein 
thrombosis. CMAJ,vol. 175,pp. 1087-1092. 
Smith, C., Mensah, A., Sameer, M., et al. 2008. Is pretest probability 
assessment on emergency department patients with suspected venous 
thromboembolism documented before SimpliRed D-dimer testing? 
CJEM,vol. 10,pp. 519-523. 
 88 
Soderberg, M., Brohult, J., Jorfeldt, L., et al. 2009. The use of D-dimer testing 
and Wells score in patients with high probability for acute pulmonary 
embolism. J Eval Clin Pract,vol. 15,pp. 129-133. 
Spencer, F., Goldberg, R., Lessard, D., et al. 2010. Factors associated with 
adverse outcomes in outpatients presenting with pulmonary embolism: 
the Worcester venous thromboembolism study. Circulation,vol. 3,pp. 
390-394. 
Tapson, V.F. 2008. Acute pulmonary embolism. NEJM,vol. 358,pp. 1037-1052. 
The Task Force for the Diagnosis and Management of Acute Pulmonary 
Embolism of the European Society of Cardiology 2008. Guidelines on 
the diagnosis and management of acute pulmonary embolism. Eur 
Heart J,vol. 29,pp. 2276-2315. 
The Task Force on Aortic Dissection European Society of Cardiology. 2001. 
Diagnosis and management of aortic dissection. Eur Heart J,vol. 22,pp. 
1642-1681. 
Tita-Nwa, F., Bos, A., Adjei, A., et al. 2010. Correlates of D-dimer in older 
persons. Aging Clin Exp Res,vol. 22,pp. 20-23. 
van Belle, A., Buller, H.R., Huisman, M.V., et al. 2006. Effectiveness of 
managing suspected pulmonary embolism using an algorithm 
combining clinical probability, D-dimer testing, and computed 
tomography. JAMA,vol. 295,pp. 172-179. 
Wakai, A., Gleeson, A. &Winter, D. 2003. Role of fibrin D-dimer testing in 
emergency medicine. Emerg Med J,vol. 20,pp. 319-325. 
 89 
Wells, P.S., Ginsberg, J.S., Anderson, D.S., et al. 1998. Use of a clinical 
model for safe management of patients with suspected pulmonary 
embolism. Ann Intern Med,vol. 129,pp. 997-1005. 
 
 
